Genomind's Series B Round

Genomind raised a round of funding on February 08, 2017.

Genomind is a personalized medicine company committed to the discovery of the underlying causes of neuropsychiatric disorders and supporting the development of personalized medicine that improves pati…

Articles about Genomind's Series B Round: